MAR-TADALAFIL

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: 4af1b8983a1d2e14
Drug Approval Canada Name: MAR-TADALAFIL
Product Name: MAR-TADALAFIL
Status: Marketed
Status Date: 2016-07-13
Original Market Date: 2016-07-13
Din: 02452251
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:12.12
Atc Original: G04BE08 TADALAFIL
Atc Name: g 04 be 08
Aig Number: 0149485001
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

TADALAFIL

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4af1b8983a1d2e14

Type

Standard